Oct.23, 2020Bharat Biotech receives Drugs Controller General of India approval to conduct Phase 3 clinical trials with 26,000 participants for Covaxin. Nov.16, 2020Read More
Oct.23, 2020Bharat Biotech receives Drugs Controller General of India approval to conduct Phase 3 clinical trials with 26,000 participants for Covaxin. Nov.16, 2020Read More
© 2020, Dr.Tianze Zhang. All rights reserved